Research Perspective: Potential Role of Nitazoxanide in Ovarian Cancer Treatment. Old Drug, New Purpose?
Among gynecological malignancies epithelial ovarian cancer (EOC) is the leading cause of death. Despite improvements in conventional chemotherapy combinations, the overall cure rate has remained mostly stable over the years, and only 10%–15% of patients maintain a complete response following first-l...
Main Authors: | Jessie Ehrisman, Nicola Di Santo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/5/3/1163 |
Similar Items
-
Foldases catalyzing the formation and isomerization of disulfide bonds in proteins /
by: 172469 Nagradova, Natalya K.
Published: (2009) -
Comparison Between Nitazoxanide and Metronidazole in the Treatment of Protozoal Diarrhea in Children
by: Asmaa A.E. Ali, et al.
Published: (2014-06-01) -
Pulmonary cryptosporidiosis in an immunocompetent host treated successfully with nitazoxanide
by: Harish Kumar, et al.
Published: (2016-01-01) -
Pan-Inhibition of Protein Disulfide Isomerase Caused Cell Death through Disrupting Cellular Proteostasis in Pancreatic Ductal Adenocarcinoma Cells
by: Ching-Sheng Hung, et al.
Published: (2023-11-01) -
Plant-Waste-Derived Sorbents for Nitazoxanide Adsorption
by: Artur Sokołowski, et al.
Published: (2023-08-01)